Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study

This study has been completed.
Sponsor:
Information provided by:
Cardiome Pharma
ClinicalTrials.gov Identifier:
NCT00526136
First received: September 5, 2007
Last updated: December 17, 2008
Last verified: December 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Estimated Primary Completion Date: No date given
No publications provided by Cardiome Pharma

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):